CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $266 | +54.7% | 8,184 | +19.8% | 0.00% | +100.0% |
Q1 2024 | $172 | -97.5% | 6,831 | -96.8% | 0.00% | -98.5% |
Q4 2023 | $6,945 | +40.4% | 213,810 | +17.7% | 0.06% | +14.0% |
Q3 2023 | $4,948 | +125.8% | 181,625 | +84.4% | 0.06% | +235.3% |
Q2 2023 | $2,191 | -45.1% | 98,476 | -46.5% | 0.02% | -63.0% |
Q1 2023 | $3,988 | +1344.9% | 184,096 | +1253.1% | 0.05% | +1433.3% |
Q4 2022 | $276 | -99.9% | 13,605 | +0.1% | 0.00% | -25.0% |
Q3 2022 | $348,000 | -59.9% | 13,592 | -62.8% | 0.00% | -55.6% |
Q2 2022 | $868,000 | -94.6% | 36,513 | -94.9% | 0.01% | -92.4% |
Q1 2022 | $16,128,000 | +182.9% | 716,183 | +148.8% | 0.12% | +280.6% |
Q4 2021 | $5,700,000 | +226.3% | 287,860 | +224.3% | 0.03% | +287.5% |
Q3 2021 | $1,747,000 | +1488.2% | 88,765 | +1674.2% | 0.01% | +700.0% |
Q2 2021 | $110,000 | -70.4% | 5,003 | -68.0% | 0.00% | -50.0% |
Q1 2021 | $372,000 | -88.0% | 15,625 | -86.8% | 0.00% | -88.2% |
Q4 2020 | $3,104,000 | -31.7% | 118,672 | -54.5% | 0.02% | -41.4% |
Q3 2020 | $4,543,000 | +6.7% | 261,037 | +3.1% | 0.03% | -17.1% |
Q2 2020 | $4,258,000 | +96.9% | 253,158 | +39.2% | 0.04% | +75.0% |
Q1 2020 | $2,162,000 | +244.8% | 181,857 | +250.8% | 0.02% | +233.3% |
Q4 2019 | $627,000 | +224.9% | 51,839 | +279.0% | 0.01% | +200.0% |
Q3 2019 | $193,000 | +82.1% | 13,679 | +44.0% | 0.00% | +100.0% |
Q2 2019 | $106,000 | -23.2% | 9,497 | -18.9% | 0.00% | 0.0% |
Q1 2019 | $138,000 | -94.1% | 11,715 | -93.3% | 0.00% | -95.2% |
Q4 2018 | $2,348,000 | +2115.1% | 175,779 | +2215.6% | 0.02% | +2000.0% |
Q3 2018 | $106,000 | -69.3% | 7,591 | -65.4% | 0.00% | -66.7% |
Q2 2018 | $345,000 | +216.5% | 21,941 | +137.1% | 0.00% | +200.0% |
Q2 2017 | $109,000 | -73.5% | 9,255 | -75.3% | 0.00% | -75.0% |
Q1 2017 | $411,000 | +170.4% | 37,533 | +79.6% | 0.00% | +300.0% |
Q4 2016 | $152,000 | +100.0% | 20,901 | -26.5% | 0.00% | – |
Q3 2014 | $76,000 | +68.9% | 28,419 | +76.5% | 0.00% | – |
Q2 2014 | $45,000 | – | 16,103 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
S&T BANK/PA | 347,260 | $7,727 | 1.39% |
FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |